🇬🇧 United Kingdom Country × Condition
prostate cancer Clinical Trials in United Kingdom
Active clinical trials for prostate cancer with research sites in United Kingdom. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇬🇧 United Kingdom
Active Trials in United Kingdom (4)
NCT07541911
Recruiting
A Study to Evaluate the Performance of Confocal Microscopy to Detect Positive Margins During Radical Prostatectomy
Enrollment
693 pts
Country
🇬🇧 United Kingdom
University College, London
View Trial → NCT06190899 Phase 1, Phase 2
Recruiting
Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
Enrollment
54 pts
Country
🇬🇧 United Kingdom
Celcuity Inc
View Trial → NCT02543905
Recruiting
The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment
Enrollment
1,600 pts
Country
🇬🇧 United Kingdom
Institute of Cancer Research, Unite...
View Trial → NCT07414940 Phase 1, Phase 2
Recruiting
ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium
Enrollment
60 pts
Country
🇬🇧 United Kingdom
University College, London
View Trial → Frequently Asked Questions
How many prostate cancer clinical trials are active in United Kingdom?
There are currently 4 active clinical trials for prostate cancer with sites in United Kingdom, of which 4 are actively recruiting patients.
How can I join a prostate cancer clinical trial in United Kingdom?
To join a prostate cancer clinical trial in United Kingdom, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in United Kingdom directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are prostate cancer trials in United Kingdom?
Active prostate cancer trials in United Kingdom span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology